2 healthcare shares I think will make a BIG recovery

Healthscope Ltd (ASX:HSO) is 1 of 2 healthcare stocks that could create great returns for any portfolio.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The number of companies providing a shock to shareholders and the market seems to be increasing. Some healthcare stocks have fallen by double digits in a single day, or by over 20% or even 30%.

Some of the falls may be completely justified. Growth companies were being priced at increasingly high earnings multiples, perhaps too highly. However, I think some of the falls in companies provide a great opportunity to buy shares at discounted prices.

Below are two healthcare companies that I think could provide great short term and long term returns:

Healthscope Ltd (ASX: HSO)

Healthscope is Australia's second-largest private hospital operator with a market capitalisation of $4 billion.

A few months ago it updated the market to say that patient numbers for the September 2016 quarter were similar to patient numbers in the 2015 quarter. If patient numbers don't rise for the whole year, then the profit can't grow either.

This created a huge sell off of the shares, going from $2.93 to today's price of $2.33. Considering the long-term aging of Australia's population and the government's desire to ease the burden on public hospitals, Healthscope could see long term growth.

I think now is a great chance to buy Healthscope shares whilst it's trading cheaply. It's trading at 20.6x FY17's estimated earnings with a dividend yield of 3.18%, which will look even more attractive once it starts franking its dividend.

Monash IVF Group Ltd (ASX: MVF)

Monash IVF is one of the two biggest IVF providers in Australia, it has a market capitalisation of $406 million.

Its main rival and competitor is Virtus Health Ltd (ASX: VRT). Virtus recently updated the market to say that Medicare data released on 25 January 2017 showed that fresh IVF cycle activity in the first half of FY17 fell by 6%, but Virtus' fresh cycle activity fell by 7.2%.

Unless Monash IVF has done a great job at stealing market share from Virtus, Monash IVF will likely also have seen a fall in IVF cycles. Monash IVF's share price fell as a result of Virtus' announcement and is still 7% lower than before the announcement. It's 32% lower than the all-time highs in October 2016.

I think the current price could be around the lowest the shares will go as they could pick up again when IVF cycles grow, even if low cost providers are taking more market share. The age families are having children is getting steadily older, which makes needing IVF services more likely.

Over the long term, I suspect Monash IVF will continue producing higher success rates and more advanced techniques to grow revenue.

Monash IVF is trading at 13.1x FY17's estimated earnings and a trailing grossed up dividend yield of 7.02%.

Time to buy?

Monash IVF clearly has the bigger dividend, however I think over the next five to ten years Healthscope will provide the best total shareholder return thanks to its impressive list of projects. For an even better dividend stock than both of these choices, you should consider our number one choice for 2017.

Motley Fool contributor Tristan Harrison owns shares of HEALTHSCPE DEF SET. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »